CIEC
VERV

Crédit Industriel et Commercial’s Verve Therapeutics VERV Stock Holding History

Crédit Industriel et Commercial’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-63,600
Closed -$714K – 436
2025
Q2 		$714K Buy
+63,600
New +$363K 0.06% 248

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Crédit Industriel et Commercial's VERV Position: Q3 2025 in Review

Crédit Industriel et Commercial sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 63,600 shares — an estimated $714K sold.

Crédit Industriel et Commercial first reported a position in VERV in Q2 2025 and held it in 1 quarter. The position peaked at $714K in Q2 2025. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • Crédit Industriel et Commercial reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Crédit Industriel et Commercial sold 63,600 Verve Therapeutics shares in Q3 2025, an estimated $714K.
  • Crédit Industriel et Commercial first reported a position in Verve Therapeutics in Q2 2025 and held it in 1 quarter.
  • Crédit Industriel et Commercial's Verve Therapeutics position peaked at $714K in Q2 2025.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on Crédit Industriel et Commercial's 13F filing for Q3 2025, filed 7 Nov 2025.